About Resilience
National Resilience, Inc. (Resilience) is a technology-focused biomanufacturing contract development and manufacturing organization (CDMO) dedicated to broadening access to complex medicines including biologics, vaccines, nucleic acids, and cell and gene therapies. Founded in 2020, it builds a sustainable network of high-tech, end-to-end manufacturing solutions across North America, partnering with biopharma companies to produce therapies quickly, safely, and at scale while protecting biopharmaceutical supply chains against disruptions.
Company details
Funding
Total raised
$2B
Last stage
Series D
Investors
Founders
Robert Nelsen
Co-founder and Managing Director of ARCH Venture Partners. Founded Resilience in 2020 based on insights into fragility of biopharmaceutical supply chains. Has helped propel ARCH to be one of the top early-stage biotech venture groups, playing a significant role in more than 100 companies.
LinkedInRahul Singhvi
Co-founder and former CEO of Resilience. Previously Operating Partner at Flagship Pioneering, COO of Takeda's Vaccine Business Unit, and President & CEO of Novavax. Holds a Sc.D. and M.S. in Chemical Engineering from MIT and an MBA from the Wharton School.
LinkedInPatrick Y. Yang
Co-Founder and Vice Chairman of Resilience. Former Executive Vice President and Global Head of Technical Operations at Roche/Genentech.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.